&nbsp;

Aug 2025

Drug

gefitinib

Other Name(s): Iressa®

Quick Link(s):

Mar 2025

Drug

gemcitabine

Other Name(s): Gemzar®

Quick Link(s):

Dec 2023

Drug

fludarabine

Other Name(s): Fludara®

Quick Link(s):

Apr 2023

Regimen

FC

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Drugs Used:

fludarabine,

cyclophosphamide

Quick Link(s):

Regimen Monograph

Apr 2016

Regimen

FLOX

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Adjuvant

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

FLUD

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Drugs Used:

fludarabine

Quick Link(s):

Regimen Monograph

Apr 2016

Regimen

FU(CIV-RT)

Cancer Type:

Gastrointestinal,

Pancreas

Intent: Adjuvant, Palliative

Drugs Used:

fluorouracil

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

GEMC

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Drugs Used:

gemcitabine

Quick Link(s):

Regimen Monograph

May 2020

Regimen

GEMC

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

gemcitabine

Quick Link(s):

Regimen Monograph

May 2020

Regimen

FCM

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2016

Regimen

FLUD+R

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma

Drugs Used: